SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...
True to Exterro's mission of accessibility and community-building, INFORM is a free-to-attend event. Participants can tailor their experience by selecting sessions that align with their interests or ...
Azimut plans to sell 80% of fintech bank to FSI by March Aims for TNB bank to operate by end of 2025 Azimut net profit could reach up to 1.25 billion euros in 2025 Milan, Jan 16 (Reuters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback